Herbion® Laksana (Tablets) Instructions for Use
Marketing Authorization Holder
Krka, D.D. (Slovenia)
ATC Code
A06AB06 (Sennosides A and B)
Active Substance
Senna (BP British Pharmacopoeia)
Dosage Form
| Herbion® Laksana | Film-coated tablets, 15 mg: 20 pcs. |
Dosage Form, Packaging, and Composition
Film-coated tablets dark brown in color, round, with a bevel.
| 1 tab. | |
| Dry standardized senna leaf extract | 33.5 mg, |
| Calculated as sennoside B | 15 mg |
Excipients : lactose monohydrate, microcrystalline cellulose, povidone, croscarmellose sodium, glycerol, colloidal anhydrous silica, magnesium stearate.
Shell composition hypromellose, propylene glycol, talc, titanium dioxide (E171), iron oxide brown (E172).
Extraction solvent methanol 60% (raw material ratio 25-45:1).
10 pcs. – blisters (2) – cardboard packs.
Clinical-Pharmacological Group
Laxative drug that stimulates intestinal peristalsis
Pharmacotherapeutic Group
Laxative
Pharmacological Action
A laxative of plant origin. Senna leaves contain dianthrone glycosides (about 3%) – sennosides A, A1, B-G; a small amount of anthraquinone glycosides, including aloe-emodin and rhein 8-glycosides; about 10% mucilage; flavonoids, including kaempferol derivatives; naphthalene glycosides.
It stimulates peristalsis of the large intestine, causing a normal bowel movement 8-10 hours after administration. It acts selectively on the colon, restores normal bowel function, and does not affect digestion.
Indications
Constipation caused by hypotension and sluggish peristalsis of the large intestine. Regulation of bowel movements in hemorrhoids, proctitis, anal fissures; spastic and atonic constipation of various etiologies.
ICD codes
| ICD-10 code | Indication |
| K59.0 | Constipation |
| K60 | Fissure and fistula of anus and rectum |
| K62.8 | Other specified diseases of anus and rectum (including proctitis) |
| K64 | Hemorrhoids and perianal venous thrombosis |
| ICD-11 code | Indication |
| DB32.1 | Slow-transit constipation |
| DB50.Z | Fissure or fistula of anal region, unspecified |
| DB6Z | Hemorrhoids or perianal venous diseases, unspecified |
| DB70.Z | Infections of anal and rectal regions, unspecified |
| DB72.Z | Some specified diseases of the anal canal, unspecified |
| DD91.1 | Functional constipation |
| DE2Z | Diseases of the digestive system, unspecified |
| EG61 | Infections of the anus or perianal skin |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take orally once daily in the evening after the last meal.
Swallow the tablet whole with a full glass of water.
For adults and children over 12 years, the typical dose is one to two tablets (15 mg to 30 mg of sennosides).
Initiate therapy with the lower dose of one tablet.
Increase to two tablets only if a single tablet does not produce a satisfactory effect.
Do not exceed the maximum daily dose of four tablets (60 mg of sennosides).
The onset of action typically occurs within 8 to 10 hours after ingestion.
Use the lowest effective dose for the shortest duration necessary to establish normal bowel function.
Limit continuous use to a maximum of one to two weeks.
Prolonged use requires medical supervision due to the risk of electrolyte imbalance and laxative dependence.
Discontinue use if abdominal pain, diarrhea, or watery stools occur.
Consult a physician if constipation persists despite one week of treatment.
This product is generally not recommended for children under 12 years of age unless directed by a physician.
Adverse Reactions
Possible allergic reactions, abdominal pain, flatulence, diarrhea; with long-term use – colitis.
Contraindications
Hypersensitivity to senna; intestinal obstruction, abdominal pain of unknown origin, water-electrolyte imbalance, acute inflammatory diseases of the abdominal organs, proctitis and hemorrhoids in the acute stage, strangulated hernia, gastrointestinal bleeding, uterine bleeding, cystitis, spastic colitis, spastic constipation; pregnancy, breastfeeding period; childhood – depending on the dosage form.
Use in Pregnancy and Lactation
Contraindicated for use during pregnancy and lactation (breastfeeding).
Use in Hepatic Impairment
Use with caution in liver diseases.
Use in Renal Impairment
Use with caution in kidney diseases.
Pediatric Use
Use in children of appropriate age categories is possible strictly according to indications, in recommended doses and dosage forms. It is necessary to strictly follow the instructions in the senna drug leaflets regarding contraindications for the use of specific senna dosage forms in children of different ages.
Special Precautions
With long-term use of senna preparations, habituation may develop, so it is advisable to alternate them with other laxatives.
Drug Interactions
Senna preparations reduce the absorption of tetracycline.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml 